跳至主要内容
临床试验/CTRI/2022/05/042804
CTRI/2022/05/042804招募中未知

A prospective interventional study to find the effectivity of Razumab by measuring macular edema pre and post intravitreal injection.

ESIC postgraduate institute of medical science and research0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • patients with diabetic macular edema or macular edema due to retinal vaso-occlussive disease with central macular thickness of less or equal to 315 micron and visual acuity of less or equal to 0.2 on LogMAR chart will be included in the study.

排除标准

  • 1. pre existing macular scar or dystrophy.
  • 2.patients with active inflammatory and infectious diseases of the eye.
  • 3. Patients already under treatment for macular edema in other hospital.
  • 4.patients with history of recent ocular history or trauma.
  • 5. patients with history of cerebrovascular or cardiovascular comorbidities.

研究者

发起方
ESIC postgraduate institute of medical science and research

相似试验